Hematology/Oncology Division

The Hematology/Oncology Division is part of the Department of Medicine and the leading specialty service for the organization of the Henry Ford Cancer Institute. As one of the largest, adult cancer institutes in Michigan, we have treated patients from across the U.S. and worldwide. We offer the complete range of diagnostic tests, advanced research therapies, and support services for cancer patients.

Clinical highlights

Our cancer institute conducts 13 multidisciplinary tumor boards regularly. We offer the full range of advanced chemotherapies and other therapies including alkylating agents, antimetabolites, antitumor antibiotics, immunotherapies, mitotic inhibitors, nitrosoureas, and hormone therapies. Our Division’s Bone Marrow/Stem Cell Transplant program offers autologous, allogeneic, and syngeneic transplants. We regularly perform some of the most complex stem cell transplants in the country.

Research

With more than 200 ongoing clinical trials, the Henry Ford Cancer Institute features a large research team focused on bench to translational to clinical research. Our Hematology/Oncology Division is active with the Southwest Oncology Group as well as other government, industry, and private funding sources for research.

Education

The Hematology and Medical Oncology Fellowship offers four positions annually. Medical students, residents, and fellows have the opportunity to work with renowned specialists and as part of multidisciplinary teams. Training provides exposure to a wide range of malignant conditions as well as a diverse patient population. We are one of a few training institutions with Schwartz Rounds, where caregivers discuss psychosocial aspects of caring for oncology patients.